Pharmacokinetics and safety of tiotropium+olodaterol 5 μg/5 μg fixed-dose combination in Chinese patients with COPD
Publication date: Available online 9 September 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Zhenlei Wang, Yusuke Tadayasu, Na Hu, Shiqing Shu, Chao Hu, Zhu Luo
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: China Health | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Respiratory Medicine | Spiriva | Tiotropium